Effects of recombinant human interleukin 11 on thrombocytopenia and neutropenia in irradiated rhesus monkeys

Radiation Research

Volumn 162, Issue 2, 2004, Pages 157-163

  Hao, Jing ^a   Sun, Liansheng ^a   Huang, Haixiao ^a   Xiong, Guolin ^a   Liu, Xiaolan ^a   Qiu, Liling ^a   Chen, Guozhi ^a   Dong, Bo ^a   Li, Yuanmin ^a   Chen, Wangqiu ^b   Buechler, Yingji ^b   Sun, Jim ^b   Shen, Chun ^b   Luo, Qingliang ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b General Instrument Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; RECOMBINANT INTERLEUKIN 11;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; COLONY FORMATION; COLONY FORMING UNIT E; CONTROLLED STUDY; DRUG EFFECT; GAMMA RADIATION; HISTOPATHOLOGY; IRRADIATION; LEUKOCYTE; MEGAKARYOCYTE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RHESUS MONKEY; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ANIMALS; FEMALE; GAMMA RAYS; INTERLEUKIN-11; MACACA MULATTA; MALE; NEUTROPENIA; PLACEBOS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

ANIMALIA; MACACA MULATTA;

EID: 4143118839     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3202     Document Type: Article

References (24)

1. S. R. Paul, F. Bennett, J. A. Calvetti, K. Kelleher, C. R. Wood, R. M. O'Hara, Jr., A. C. Lear, B. Sibley, S. C. Clark and Y. C. Yang, Molecular cloning of a cDNA encoding interleukin 11, a novel stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87, 7512-7516 (1990).
2. G. Walsh, Biopharmaceuticals: Biochemistry and Biotechnology, pp. 204-205. Wiley, New York, 1999.
3. N. S. Weich, A. Wang, M. Fitzgerald, T. Y. Neben, D. Donaldson, J. Calvetti, J. Yetz-Aldape, R. M. Leven and K. J. Turner, Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood 90, 3893-3902 (1997).
4. G. Hangoc, T. Yin, S. Cooper, P. Schendel, Y. C. Yang and H. E. Broxmeyer, In vivo effects of recombinant human interleukin-11 on myelopoiesis in mice. Blood 81, 965-972 (1993).
5. T. Y. Nenben, J. Leobelenz, L. Hayes, K. McCarthy, J. Stoudemire, R. Schaub and S. J. Goldman, Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 81, 901-908 (1993).
6. J. P. Leonard, T. Y. Neben, M. K. Kozitza, C. M. Quinto and S. J. Goldman, Constant subcutaneous infusion of rhIL-11 in mice: Efficient delivery enhances biological activity. Exp. Hematol. 24, 270-276 (1996).
7. M. S. Cairo, J. M. Plunkett, P. Schendel and C. van de Yen, The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: Significant enhancement of the absolute neutrophil count. Exp. Hematol. 22, 1118-1123 (1994).
8. M. S. Cairo, J. M. Plunkett, A. Nguyen, P. Schendel and C. van de Ven, Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor. Pediatr. Res. 34, 56-61 (1993).
9. G. De Haan, B. Dontje, C. Engel, M. Loeffler and W. Nijhof, In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. Br. J. Haematol. 90, 783-790 (1995).
10. X. X. Du, T. Neben, S. Goldman and D. A. Williams, Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: Acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81, 27-34 (1993).
11. S. R. Paul, L. L. Hayes, R. Palmer, G. E. Morris, T. Y. Neben, J. Loebelenz, G. Pedneault, J. Brooks, I. Blue and C. R. Wood, Interleukin-11 expression in donor bone marrow cells improves hematological reconstitution in lethally irradiated recipient mice. Exp. Hematol. 22, 295-301 (1994).
12. M. C. Galmiche, C. A. Vogel, A. B. Delaloye, P. M. Schmidt, F. Healy, J. P. Mach and F. Buchegger, Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice. Exp. Hematol. 24, 1298-1306 (1996).
13. D. Frasca, C. Pioli, F. Guidi, S. Pucci, M. Arbitrio, G. Leter and G. Doria, IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation. Int. Immumol. 8, 1651-1657 (1996).
14. D. Frasca, F. Guidi, M. Arbitrio, C. Pioli, G. Leter, M. Spano and G. Doria, Use of hematopoietic cytokines to accelerate the recovery of the immune system in irradiated mice. Exp. Hematol. 25, 1167-1171 (1997).
15. R. A. Nash, K. Seidel, R. Storb, S. Slichter, F. G. Schuening, F. R. Appelbaum, A. B. Becker, L. Bolles, H. J. Deeg and S. A. Burstein, Effects of rhIL-11 on normal dogs and after sublethal radiation. Exp. Hematol. 23, 389-396 (1995).
16. A. Orazi, R. J. Cooper, J. Tong, M. S. Gordon, L. Battiato, G. W. Sledge, Jr., J. A. Kaye, M. Kahsai and R. Hoffman, Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow. Exp. Hematol. 24, 1289-1297 (1996).
17. C. Issacs, N. J. Robert, F. A. Bailey, M. W. Schuster, B. Overmoyer, M. Graham, B. Cai, K. J. Beach, J. W. Loewy and J. A. Kaye, Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J. Clin. Oncol. 15, 3368-3377 (1997).
18. M. S. Gordon, W. J. McCaskill-Stevens, L. A. Battiato, J. Leow, D. Loesch, E. Breeden, R. Hoffman, K. J. Beach, B. Kuca and G. W. Sledge, Jr., A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87, 3615-3624 (1996).
19. I. Tepler, L. Elias, J. W. Smith, 2nd, M. Hussein, G. Rosen, A. Y. Chang, J. O. Moore, M. S. Gordon, B. Kuca and J. A. Kaye, A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87, 3607-3614 (1996).
20. F. J. Schlerman, A. G. Bree, M. D. Kaviani, S. L. Nagle, L. H. Donnelly, L. E. Mason, R. G. Schaub, S. A. Grupp and S. J. Goldman, Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates. Stem Cells 14, 517-532 (1996).
21. Y. Yonemura, M. Kawakita, T. Masuda, K. Fujimoto, K. Kato and K. Takatsuki, Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp. Hematol. 20, 1011-1016 (1992).
22. S. Neben, D. Donaldson, C. Sieff, P. Mauch, D. Bodine, J. Ferrara, J. Yetz-Aldape and K. Turner, Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp. Hematol. 22, 353-359 (1994).
23. K. H. Dykstra, H. Rogge, A. Stone, J. Loewy, J. C. Keith and U. S. Schwertschlag, Mechanism and amelioration of recombinant human interleukin-11 (rhIL-11)-induced anemia in healthy subjects. J. Clin. Pharmacol. 40, 880-888 (2000).
24. N. S. Weich, M. Fitzgerald, A. Wang, J. Calvetti, J. Yetz-Aldape, S. Neben and K. J. Turner, Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro. Blood 95, 503-509 (2000).